Stem cell transplantation for nervous system disorders in Italy, European Union, and Ukraine: Clinical approach and governmental policies
Dario Siniscalco1, Nataliia Sych2
1 Department of Experimental Medicine, Second University of Naples, Napoli 80138, Italy;
2 Clinical Department, Cell Therapy Center EmCell, Kiev 04073, Ukraine
Stem cell transplantation for nervous system disorders in Italy, European Union, and Ukraine: Clinical approach and governmental policies
Dario Siniscalco1, Nataliia Sych2
1 Department of Experimental Medicine, Second University of Naples, Napoli 80138, Italy;
2 Clinical Department, Cell Therapy Center EmCell, Kiev 04073, Ukraine
摘要 Several debates have been raised over the use of stem cells in the field of regenerative medicine. Indeed, stem cell transplantation must follow strict rules. However, to date, many differences exist among different Western and Eastern European countries. This brief review summarizes the state-of-the-art stem cell regulation in Italy, European Union, and Ukraine.
Abstract: Several debates have been raised over the use of stem cells in the field of regenerative medicine. Indeed, stem cell transplantation must follow strict rules. However, to date, many differences exist among different Western and Eastern European countries. This brief review summarizes the state-of-the-art stem cell regulation in Italy, European Union, and Ukraine.
Dario Siniscalco, Nataliia Sych. Stem cell transplantation for nervous system disorders in Italy, European Union, and Ukraine: Clinical approach and governmental policies[J]. 临床转化神经科学, 2015, 1(2): 125-127.
Dario Siniscalco, Nataliia Sych. Stem cell transplantation for nervous system disorders in Italy, European Union, and Ukraine: Clinical approach and governmental policies. Translational Neuroscience and Clinics, 2015, 1(2): 125-127.
[1] http://www.camera.it/parlam/leggi/04040L.htm
[2] http://www.eurostemcell.org/regulations/regulation-stemcell-research-italy
[3] http://leg16.camera.it/561?appro=286
[4] Siniscalco D. Suspended life-Stem cells:Are treatments possible? J Regen Med 2012, 2:1.
[5] http://www.agenziafarmaco.gov.it/it/content/normativa-diriferimento-sperimentazione-clinica
[6] Abbott A. Leaked files slam stem-cell therapy. Nature News 2014, 505:139-140.
[7] http://www.normattiva.it/uri-res/N2Ls?urn:nir:stato:decreto.legge:2013-03-25;24!vig=
[8] http://www.normattiva.it/uri-res/N2Ls?urn:nir:stato:legge:2013-05-23;57
[9] http://www.corriere.it/cronache/14_ottobre_02/staminacomitato-esperti-boccia-metodo-no-sperimentazione-84afe122-4a74-11e4-9fe4-a545a65e6beb.shtml
[10] http://ec.europa.eu/health/human-use/clinical-trials/regulation/index_en.htm#ct1
[11] http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2004:102:0048:0058:en:PDF
[12] http://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=OJ:L:2015:093:FULL&from=EN#page=58
[13] Elstner A, Damaschun A, Kurtz A, Stacey G, Arán B, Veiga A, Borstlap J. The changing landscape of European and international regulation on embryonic stem cell research. Stem Cell Res 2009, 2(2):101-107.
[14] http://search.ligazakon.ua/l_doc2.nsf/link1/RE20973.html